Application of professor 's academic thought " is often insufficient, but is often surplus" in heat-sensitive moxibustion for tumor rehabilitation.
10.13703/j.0255-2930.20190701-k0003
- Author:
Xian-Bao HUANG
1
;
Yan-Qi CHEN
2
;
Ding-Yi XIE
1
;
Ri-Xin CHEN
1
Author Information
1. Affiliated Hospital of Jiangxi University of TCM, Nanchang 330006, China.
2. College of Acupuncture-Moxibustion and Tuina, Jiangxi University of TCM.
- Publication Type:Journal Article
- Keywords:
CHEN Ri-xin;
experience of famous doctor;
heat-sensitive moxibustion;
tumor;
yang is often insufficient;
yin is often surplus
- MeSH:
Hot Temperature;
Humans;
Medicine, Chinese Traditional;
Moxibustion;
Neoplasms;
therapy;
Quality of Life
- From:
Chinese Acupuncture & Moxibustion
2020;40(1):79-83
- CountryChina
- Language:Chinese
-
Abstract:
Professor has explored the causes of the characteristics of TCM syndromes in modern disease spectrum and pointed out that the TCM syndromes are generally characterized by " is often insufficient, but is often surplus". Based on the clinical experience and the understanding of TCM classics and ancient literature on tumor, professor has proposed that TCM syndromes of patients with advanced tumor are also generally characterized by " is often insufficient, but is often surplus". The heat-sensitive moxibustion has the functions of warming and nourishing eliminating dampness, warming meridians and dispersing cold, activating blood circulation and clearing collaterals, therefore tumor patients with deficiency syndrome (-deficiency, deficiency), cold syndrome, dampness syndrome, phlegm syndrome and blood-stasis syndrome belonging to the indications of heat-sensitive moxibustion. The heat-sensitive moxibustion has unique advantages in treating spleen-stomach dysfunction after chemotherapy and radiotherapy, bone marrow suppression after chemotherapy and radiotherapy, cancerous deficiency, cancerous pain, pleural effusion, ascites, constipation, which has important clinical value in improving the quality of life and prolonging the life time for patients with advanced tumors.
